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Despite abundant published data concerning the biochemical 
and physiological effects of adrenaline and other catechol-
amines, little is known about possible genotoxic and mutagenic 
effects. There is an interesting experimental finding that dopa-
mine induces DNA strand breaks in human skin fibroblasts and 
gene mutations in mouse lymphoma cells (M o l d e u s  et al., 
1983). However, dopamine did not exhibit genotoxic effects in 
the Salmonella/mammalian-microsome mutagenicity test, the 
sex-linked recessive lethal test in Drosophila melanogaster, the 
sister chromatid exchange (SCE) test in human lymphocytes , or 
the in vivo micronucleus assay in mouse and rat (M o l d e u s  et 
al., 1983). Likewise, in cytogenetic analysis, adrenaline did not 
exhibit genotoxic effects on cultured human peripheral blood 
lymphocytes (D j e l i ć , 1997). On the other hand, mutagenic 
effects of various catecholamines on mouse lymphoma cells 
resulted from the creation of superoxide anion (M c G r e g o r  et 
al., 1988). In addition, catechol derivates, including adrenaline, 
induce DNA strand breakage by ferryl species, whereas the 
induction of 8-hydroxyguanine (8OHG) is due to a hydroxyl 
radical (·OH) (M i u r a  et al., 2000).
More recent studies revealed that noradrenaline induces 
primary DNA damage in the Comet assay on purified human 
lymphocytes (D j e l i ć  and A n d e r s o n , 2003) and sperm 
(D o b r z y n s k a  et al., 2004), most likely due to formation 
of reactive oxygen species (ROS). This result is in agreement 
with findings that adrenaline and other catecholamines can 
be involved in redox cycling under the influence of superox-
ide anion (G e n o v a  et al., 2006). Interestingly, superoxide 
anion may induce chromosome breakage and sister chromatid 
exchange (SCE) (M ’  b e m b a -M e k a  et al., 2007).
The cytogenetic effects of adrenaline were evaluated on 
cultured human peripheral blood lymphocytes. Lymphocyte 
cultures were set up according to the protocol of R o o n e y  and 
C z e p u l k o w s k i  (1986), as described previously (D j e l i ć  et 
al., 2007). Two adrenaline exposure times were used (24 and 
48 h), appropriate concentrations (0.01 to 150 μM, Table 1) 
of adrenaline hydrochloride (Jugoremedija, Zrenjanin, Serbia) 
being added to the culture vials at 24 h of incubation for the 
experiment with 48-h exposure and at 48 h for the one with 24-
h exposure. A negative control was prepared by Jugoremedija 
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Table 1. Analysis of chromosome gaps and break frequencies and the mitotic index in whole-blood cultures of human lymphocytes treated with 
adrenaline for 24 or 48 h: results from three donors. G – gaps (not included in statistical data); CB - chromatid breaks; IB - isochromatid breaks; CE 
- chromatid exchanges; IE - isochromatid exchanges; MI – mitotic index; A total of 300 well-spread metaphases per each concentration were deter-
mined. *P< 0.05, **P< 0.01, and ***P< 0.001 (χ2 test).
SHORT COMMUNICATION
24 h exposure 48 h exposure
Adrenaline concentrations  (µM) 
plus negative and positive controls
Types of 
chromosomal 
changes
Breaks 
per metaphase
Types of 
chromosomal 
changes
Breaks
per metaphase
G CB IB CE IE (%) ± SD MI (%) G CB IB CE IE (%) ± SD MI (%)
Untreated 8 4 1 1.67 ±  0.13 4.70 6 2 2 1 2.00 ±  0.16 5.11
Negative control 10 4 1.33 ±  0.11 5.08 7 5 1.67 ±  0.13 6.22
Adrenaline 0.01 µM 7 5 1.67 ±  0.13 4.65 6 3 1 1.33 ±  0.11 5.17
Adrenaline 0.2   µM 5 2 1 1.00 ±  0.10 4.12 12 3 1 1.33 ±  0.15 5.94
Adrenaline 1      µM 6 4 1 2.00 ±  0.16 4.78 7 2 0.67 ±  0.08 4.43
Adrenaline 5      µM 11 3 1.00 ±  0.10 3.36* 10 4 1 1.67 ±  0.13 3.70**
Adrenaline 50    µM 8 6 1 2.33 ±  0.15 2.25*** 9 5 1 2.00 ±  0.14 2.42***
Adrenaline 150  µM 9 5 1.67 ±  0.13 2.09*** 10 6 1 1 2.67 ±  0.19 1.98***
Positive control (MNNG) 26 17 9 4 2 12.67 ±  0.39*** 1.89*** 38 31 11 2 3 17.33 ±  0.42*** 1.46***
as a solution which contains all compounds except the active 
ingredient – adrenaline. A well-known mutagen, N-methyl-
N’-nitro-N-nitrosoguanidine (MNNG), was used as a positive 
control, at a final concentration of 1 μM. Two hours before 
harvesting, colcemid (0.5 μg/mL) (Ciba, Basel, Switzerland) was 
added to the cultures. Hypotonic treatment, fixation, and stain-
ing were described elsewhere (D j e l i ć  et al., 2007). We scored 
100 mitotic plates per donor for each experimental concentra-
tion and controls. Scoring of gaps and breaks was performed 
according to B r o g g e r  (1982), and the mitotic index (MI) was 
calculated as the percentage of cells in mitosis based on at least 
2000 cells per donor. Statistical analysis was performed with 
the χ2 test.
Experimental values of chromosome breakage and mitotic 
indices are presented in Table 1. It is evident that under the 
experimental conditions of this investigation, adrenaline did 
not cause significant changes in breaks per cell in comparison 
with either the negative control or untreated cultures at either 
exposure time (24 and 48 h). As expected, the positive control 
(MNNG) caused significant clastogenic effects in the guise of an 
increase in breaks and chromatid and isochromatid exchanges 
(P < 0.001) at both exposure times (24 and 48 h), thereby 
indicating that the experimental conditions were suitable for 
detection of clastogenic effects. On the other hand, there is a 
decrease in the mitotic index at the three highest concentrations 
of adrenaline (5, 50, and 150 μM). 
The lack of clastogenic effects of adrenaline observed in this 
investigation is in accordance with results of genotoxicity evalu-
ation of chemically similar dopamine, which did not induce 
sister chromatid exchanges in cultured human lymphocytes 
(M o l d e u s  et al., 1983). On the other hand, noradrenaline had 
profound DNA damaging effects in the Comet assay on puri-
fied human lymphocytes (D j e l i ć  and A n d e r s o n , 2003). 
However, it should be pointed out that effects of noradrenaline 
in the Comet assay were monitored on purified lymphocytes, 
whereas in the present investigation we used whole-blood 
lymphocytes. This is important to mention because purified 
lymphocytes are more susceptible to DNA damage by ROS 
than lymphocytes in whole-blood cultures (A n d r e o l i  et al., 
1999). Therefore, had we used purified lymphocytes, the effects 
of adrenaline might have been significant. This is conceiv-
able because catechol groups can be involved in redox cycling 
accompanied by ROS generation, which favors oxidative stress 
(D o b r z y n s k a  et al., 2004). Indeed, M c  G r e g o r  et al. 
(1988) investigated catecholamines and related substances and 
showed that although the phenolic group was not mutagenic, 
the addition of a catehol-forming second hydrohyl group was 
sufficient to create a mutagenic agent. 
Finally, decrease in the mitotic index is in accordance 
with findings that teophylline inhibits proliferation of cultured 
human lymphocytes (K o t e c k i  et al., 1989). To be specific, the 
molecular mechanism of signal transduction of both adrenaline 
and teophylline implies increase in the concentration of intra-
cellular cAMP. Increased cAMP may have contributed to the 
mitotic index decrease observed in this investigation. Moreover, 
it has been shown that stimulation of β-adrenoceptors with iso-
proterenol decreases the proliferative response of lymphocytes 
to mitogens. Also, there is a marked increase of intracellular 
cAMP in lymphocytes exposed to isproterenol and mitogens 
(C a r l s o n  et al., 1994). Since naturally occuring catechol-
amines inhibit the proliferation of T-lymphocytes (B a r t i k  et 
al., 1994), we assume that stimulation of adrenergic receptors 
by adrenaline may have been responsible, at least in part, for MI 
decrease. In addition, arrest of mitosis due to repair of genetic 
damage may have contributed to decreased values of MI.
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